Skip to content

Sources — uterine adenosarcoma patient-voice layer

Last curated: 2026-09-01.

(a) Organisation pages fetched

Source URL Accessed What was used
Foundation for Women’s Cancer homepage https://foundationforwomenscancer.org/ 2026-09-01 Mission, SGO partnership, education/research/public-awareness remit
Sarcoma UK homepage https://sarcoma.org.uk/ 2026-09-01 Support line, 5,900 UK sarcoma diagnoses/year, research investment, contact details
Sarcoma Foundation of America homepage https://curesarcoma.org/ automated re-fetch blocked 2026-09-01 HTTP 403 prevented independent verification; exact changing claims removed from the directory
Sarcoma Alliance homepage https://sarcomaalliance.org/ 2026-09-01 Assistance with cost of expert second opinions
NCI PDQ uterine sarcoma, patient version https://www.cancer.gov/types/uterine/patient/uterine-sarcoma-treatment-pdq 2026-09-01 Adenosarcoma named; signs; FIGO adenosarcoma staging; tamoxifen as uterine-sarcoma risk factor
American Cancer Society uterine-sarcoma detection/diagnosis/staging hub https://www.cancer.org/cancer/types/uterine-sarcoma/detection-diagnosis-staging.html 2026-09-01 General information hub; the previously cited “questions to ask” URL now redirects here, so the question-list claim was removed

(b) News / features

None fetched as stand-alone features. Sarcoma UK’s National Sarcoma Survey 2025 and “Unique Among Cancers” report were seen as homepage cards; the full reports were not retrieved this session and are not cited for numbers.

(c) Video

Not used. No adenosarcoma-specific video listing was retrieved and watched.

(d) Published qualitative and patient-experience research (PMIDs live this session)

Coverage limits

  1. No adenosarcoma-specific qualitative study. Themes inherit uterine-sarcoma-class findings from n=13 mixed histologies. A 2026 n=1 perspective exists but cannot establish a theme. LMS, ESS and adenosarcoma are not the same illness; sexual-function and menopausal themes may apply more to hysterectomy/BSO as an operation than to adenosarcoma as a histology.
  2. Closed groups not accessed. Gynae Sarcoma email forum and Facebook ESS/sarcoma groups are signposted only.
  3. Organisation story hubs were treated as evidence that stories are collected, not as a source of individual narratives.
  4. Sarcoma UK survey/report numbers were not taken from homepage cards.
  5. NCCN patient materials were not fetched.
  6. Non-English patient organisations (beyond FWC’s advertised Arabic/Spanish educational resources) were not systematically searched; this layer is English-language biased.